CRSP icon

CRISPR Therapeutics

253 hedge funds and large institutions have $1.92B invested in CRISPR Therapeutics in 2019 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 68 increasing their positions, 52 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
253
Holders Change
+71
Holders Change %
+39.01%
% of All Funds
5%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
91
Increased
68
Reduced
52
Closed
18
Calls
$55.6M
Puts
$58.2M
Net Calls
-$2.58M
Net Calls Change
-$3.6M
Name Holding Trade Value Shares
Change
Shares
Change %
ECM
251
Estabrook Capital Management
New York
$731 +$731 +12 New
WCA
252
Windsor Creek Advisors
Vermont
$305 +$305 +5,000 New
OTPPB
253
Ontario Teachers' Pension Plan Board
Ontario, Canada
-$13.2M -320,845 Closed
ACP
254
Acuta Capital Partners
California
-$5.49M -134,000 Closed
SPPAM
255
Summit Partners Public Asset Management
Massachusetts
-$5.12M -125,000 Closed
Korea Investment Corp
256
Korea Investment Corp
South Korea
-$1.86M -45,300 Closed
ACM
257
Asymmetry Capital Management
California
-$1.52M -37,141 Closed
SSA
258
Schonfeld Strategic Advisors
New York
-$1.08M -26,420 Closed
First Trust Advisors
259
First Trust Advisors
Illinois
-$987K -24,085 Closed
AIC
260
Archer Investment Corporation
Indiana
-$307K -7,500 Closed
TCM
261
Traynor Capital Management
Pennsylvania
-$280K -6,845 Closed
Point72 Asset Management
262
Point72 Asset Management
Connecticut
-$265K -6,456 Closed
HAG
263
HighPoint Advisor Group
Illinois
-$171K -3,400 Closed
Walleye Capital
264
Walleye Capital
New York
-$64K -1,555 Closed
BWP
265
BSW Wealth Partners
Colorado
-$34K -840 Closed
SF
266
Synovus Financial
Georgia
-$20K -500 Closed
BFEC
267
Benjamin F. Edwards & Company
Missouri
-$16K -400 Closed
AA
268
AlphaMark Advisors
Kentucky
-$4K -94 Closed
EWM
269
Elmwood Wealth Management
California
-$3K -66 Closed
LC
270
Lindbrook Capital
California
-$2K -55 Closed